Literature DB >> 18480910

Cucurbit[7]uril host-guest complexes of the histamine H2-receptor antagonist ranitidine.

Ruibing Wang1, Donal H Macartney.   

Abstract

The macrocyclic host cucurbit[7]uril forms very stable complexes with the diprotonated (K(CB[7])(1) = 1.8 x 10(8) dm(3) mol(-1)), monoprotonated (K(CB[7])(2) = 1.0 x 10(7) dm(3) mol(-1)), and neutral (K(CB[7])(3) = 1.2 x 10(3) dm(3) mol(-1)) forms of the histamine H(2)-receptor antagonist ranitidine in aqueous solution. The complexation behaviour was investigated using (1)H NMR and UV-visible spectroscopy as a function of pH and the pK(a) values of the guest were observed to increase (DeltapK(a1) = 1.5 and DeltapK(a2) = 1.6) upon host-guest complex formation. The energy-minimized structures of the host-guest complexes with the cationic guests were determined and provide agreement with the NMR results indicating the location of the CB[7] over the central portion of the guest. The inclusion of the monoprotonated form of ranitidine slows the normally rapid (E)-(Z) exchange process and generates a preference for the (Z) isomer. The formation of the CB[7] host-guest complex greatly increases the thermal stability of ranitidine in acidic aqueous solution at 50 degrees C, but has no effect on its photochemical reactivity.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18480910     DOI: 10.1039/b801591k

Source DB:  PubMed          Journal:  Org Biomol Chem        ISSN: 1477-0520            Impact factor:   3.876


  3 in total

1.  Topical cream-based dosage forms of the macrocyclic drug delivery vehicle cucurbit[6]uril.

Authors:  Marian Seif; Michael L Impelido; Michael G Apps; Nial J Wheate
Journal:  PLoS One       Date:  2014-01-15       Impact factor: 3.240

Review 2.  Applications of Cucurbiturils in Medicinal Chemistry and Chemical Biology.

Authors:  Debapratim Das; Khaleel I Assaf; Werner M Nau
Journal:  Front Chem       Date:  2019-09-13       Impact factor: 5.221

3.  Interaction of Cucurbit[7]uril with Oxime K027, Atropine, and Paraoxon: Risky or Advantageous Delivery System?

Authors:  Jana Zdarova Karasova; Martin Mzik; Tomas Kucera; Zbynek Vecera; Jiri Kassa; Vit Sestak
Journal:  Int J Mol Sci       Date:  2020-10-23       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.